Therapeutic	0	11	O
Electromagnetic	12	27	O
Field	28	33	O
(	34	35	O
TEMF	35	39	O
)	39	40	O
and	41	44	O
gamma	45	50	O
irradiation	51	62	O
on	63	65	O
human	66	71	B-Organism
breast	72	78	B-Pathological_formation
cancer	79	85	I-Pathological_formation
xenograft	86	95	I-Pathological_formation
growth	96	102	O
,	102	103	O
angiogenesis	104	116	O
and	117	120	O
metastasis	121	131	O
.	131	132	O

BACKGROUND	134	144	O
:	144	145	O
The	146	149	O
effects	150	157	O
of	158	160	O
a	161	162	O
rectified	163	172	O
semi	173	177	O
-	177	178	O
sinewave	178	186	O
signal	187	193	O
(	194	195	O
15	195	197	O
mT	198	200	O
amplitude	201	210	O
,	210	211	O
120	212	215	O
pulses	216	222	O
per	223	226	O
second	227	233	O
,	233	234	O
EMF	235	238	O
Therapeutics	239	251	O
,	251	252	O
Inc	253	256	O
.	256	257	O
)	257	258	O
(	259	260	O
TEMF	260	264	O
)	264	265	O
alone	266	271	O
and	272	275	O
in	276	278	O
combination	279	290	O
with	291	295	O
gamma	296	301	O
irradiation	302	313	O
(	314	315	O
IR	315	317	O
)	317	318	O
therapy	319	326	O
in	327	329	O
nude	330	334	B-Organism
mice	335	339	I-Organism
bearing	340	347	O
a	348	349	O
human	350	355	B-Organism
MDA	356	359	B-Pathological_formation
MB231	360	365	I-Pathological_formation
breast	366	372	I-Pathological_formation
cancer	373	379	I-Pathological_formation
xenograft	380	389	I-Pathological_formation
were	390	394	O
tested	395	401	O
.	401	402	O

Green	403	408	B-Gene_or_gene_product
fluorescence	409	421	I-Gene_or_gene_product
protein	422	429	I-Gene_or_gene_product
transfected	430	441	O
cancer	442	448	B-Cell
cells	449	454	I-Cell
were	455	459	O
injected	460	468	O
into	469	473	O
the	474	477	O
mammary	478	485	B-Tissue
fat	486	489	I-Tissue
pad	490	493	I-Tissue
of	494	496	O
young	497	502	O
female	503	509	O
mice	510	514	B-Organism
.	514	515	O

Six	516	519	O
weeks	520	525	O
later	526	531	O
,	531	532	O
mice	533	537	B-Organism
were	538	542	O
randomly	543	551	O
divided	552	559	O
into	560	564	O
four	565	569	O
treatment	570	579	O
groups	580	586	O
:	586	587	O
untreated	588	597	O
controls	598	606	O
;	606	607	O
10	608	610	O
minute	611	617	O
daily	618	623	O
TEMF	624	628	O
;	628	629	O
200	630	633	O
cGy	634	637	O
of	638	640	O
IR	641	643	O
every	644	649	O
other	650	655	O
day	656	659	O
(	660	661	O
total	661	666	O
800	667	670	O
cGy	671	674	O
)	674	675	O
;	675	676	O
IR	677	679	O
plus	680	684	O
daily	685	690	O
TEMF	691	695	O
.	695	696	O

Some	697	701	O
mice	702	706	B-Organism
in	707	709	O
each	710	714	O
group	715	720	O
were	721	725	O
euthanized	726	736	O
24	737	739	O
hours	740	745	O
after	746	751	O
the	752	755	O
end	756	759	O
of	760	762	O
IR	763	765	O
.	765	766	O

TEMF	767	771	O
treatment	772	781	O
continued	782	791	O
for	792	795	O
3	796	797	O
additional	798	808	O
weeks	809	814	O
.	814	815	O

Tumor	816	821	B-Pathological_formation
sections	822	830	I-Pathological_formation
were	831	835	O
stained	836	843	O
for	844	847	O
:	847	848	O
endothelial	849	860	B-Cell
cells	861	866	I-Cell
with	867	871	O
CD31	872	876	B-Gene_or_gene_product
and	877	880	O
PAS	881	884	B-Drug_or_compound
or	885	887	O
hypoxia	888	895	B-Gene_or_gene_product
inducible	896	905	I-Gene_or_gene_product
factor	906	912	I-Gene_or_gene_product
1alpha	913	919	I-Gene_or_gene_product
(	920	921	O
HIF	921	924	B-Gene_or_gene_product
)	924	925	O
.	925	926	O

RESULTS	927	934	O
:	934	935	O
Most	936	940	O
tumors	941	947	B-Pathological_formation
less	949	953	O
than	954	958	O
35	959	961	O
mm3	962	965	O
were	966	970	O
white	971	976	O
but	977	980	O
tumors	981	987	B-Pathological_formation
greater	989	996	O
than	997	1001	O
35	1002	1004	O
mm3	1005	1008	O
were	1009	1013	O
pink	1014	1018	O
and	1019	1022	O
had	1023	1026	O
a	1027	1028	O
vascularized	1029	1041	B-Pathological_formation
capsule	1042	1049	I-Pathological_formation
.	1049	1050	O

The	1051	1054	O
cortex	1055	1061	B-Pathological_formation
within	1062	1068	O
100	1069	1072	O
microns	1073	1080	O
of	1081	1083	O
the	1084	1087	O
capsule	1088	1095	B-Pathological_formation
had	1096	1099	O
little	1100	1106	O
vascularization	1107	1122	O
.	1122	1123	O

Blood	1124	1129	B-Multi-tissue_structure
vessels	1130	1137	I-Multi-tissue_structure
,	1137	1138	O
capillaries	1139	1150	B-Tissue
,	1150	1151	O
and	1152	1155	O
endothelial	1156	1167	B-Cellular_component
pseudopods	1168	1178	I-Cellular_component
were	1179	1183	O
found	1184	1189	O
at	1190	1192	O
greater	1194	1201	O
than	1202	1206	O
100	1207	1210	O
microns	1211	1218	O
from	1219	1223	O
the	1224	1227	O
capsule	1228	1235	B-Pathological_formation
(	1236	1237	O
subcortex	1237	1246	B-Pathological_formation
)	1246	1247	O
.	1247	1248	O

Tumors	1249	1255	B-Pathological_formation
greater	1257	1264	O
than	1265	1269	O
35	1270	1272	O
mm3	1273	1276	O
treated	1277	1284	O
with	1285	1289	O
IR	1290	1292	O
24	1293	1295	O
hours	1296	1301	O
previously	1302	1312	O
or	1313	1315	O
with	1316	1320	O
TEMF	1321	1325	O
had	1326	1329	O
decreased	1330	1339	O
blood	1340	1345	B-Multi-tissue_structure
vessels	1346	1353	I-Multi-tissue_structure
in	1354	1356	O
the	1357	1360	O
subcortex	1361	1370	B-Pathological_formation
and	1371	1374	O
more	1375	1379	O
endothelial	1380	1391	B-Cellular_component
pseudopods	1392	1402	I-Cellular_component
projecting	1403	1413	O
into	1414	1418	O
hypoxic	1419	1426	O
,	1426	1427	O
HIF	1428	1431	B-Gene_or_gene_product
positive	1432	1440	O
areas	1441	1446	O
than	1447	1451	O
tumors	1452	1458	B-Pathological_formation
from	1459	1463	O
the	1464	1467	O
control	1468	1475	O
group	1476	1481	O
.	1481	1482	O

Mice	1483	1487	B-Organism
that	1488	1492	O
received	1493	1501	O
either	1502	1508	O
IR	1509	1511	O
or	1512	1514	O
TEMF	1515	1519	O
had	1520	1523	O
significantly	1524	1537	O
fewer	1538	1543	O
lung	1544	1548	B-Organ
metastatic	1549	1559	O
sites	1560	1565	O
and	1566	1569	O
slower	1570	1576	O
tumor	1577	1582	B-Pathological_formation
growth	1583	1589	O
than	1590	1594	O
did	1595	1598	O
untreated	1599	1608	O
mice	1609	1613	B-Organism
.	1613	1614	O

No	1615	1617	O
harmful	1618	1625	O
side	1626	1630	O
effects	1631	1638	O
were	1639	1643	O
attributed	1644	1654	O
to	1655	1657	O
TEMF	1658	1662	O
.	1662	1663	O

CONCLUSION	1664	1674	O
:	1674	1675	O
TEMF	1676	1680	O
therapy	1681	1688	O
provided	1689	1697	O
a	1698	1699	O
safe	1700	1704	O
means	1705	1710	O
for	1711	1714	O
retarding	1715	1724	O
tumor	1725	1730	B-Pathological_formation
vascularization	1731	1746	O
,	1746	1747	O
growth	1748	1754	O
and	1755	1758	O
metastasis	1759	1769	O
.	1769	1770	O

